HomeStock ScreenerTejnaksh Healthcare

Tejnaksh Healthcare Share Price | Tejnaksh Healthcare Stock Screener

TEJNAKSH Healthcare Service Provider
Share Price BSE
₹15.39
▲ 0.27 (1.79%)
2026-05-27 00:00:00
As of May 27, 2026, the Tejnaksh Healthcare share price (BSE: TEJNAKSH) is ₹15.39, up 1.79% from the previous close, with shares trading between ₹15.39 and ₹15.55, and a 52-week range of ₹11.18–₹22.23. Check Tejnaksh Healthcare yearly highs lows for the annual price range and momentum. Use the Tejnaksh Healthcare stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Tejnaksh Healthcare Market Cap ₹29.98 Cr.
TEJNAKSH P/E Ratio (TTM) 23.26
Tejnaksh Healthcare P/B Ratio 1.16
EPS (TTM) ₹1.15
Dividend Yield -
Debt to Equity 0.12
TEJNAKSH 52 Week High ₹22.23
Tejnaksh Healthcare 52 Week Low ₹11.18
Operating Margin 22.00%
Profit Margin -
TEJNAKSH Revenue (TTM) ₹3.00
EBITDA ₹1.00
Net Income -
Total Assets ₹30.00
Total Equity ₹27.00

Tejnaksh Healthcare Share Price Chart

Screen Tejnaksh Healthcare share price with an interactive chart. Analyse TEJNAKSH price trends and volatility across different timeframes.

Tejnaksh Healthcare Company Profile - Fundamental Screener

Screen Tejnaksh Healthcare company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for TEJNAKSH shares.
Sector Healthcare Services
Industry Healthcare Service Provider
Sub-Sector Healthcare Service Provider
Segment E
ISIN INE030T01027

Tejnaksh Healthcare Balance Sheet Screener

Screen TEJNAKSH balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
Item 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Assets
Total Assets 30 31 31 30 25 25 22 20 16 7
Current Assets 6 6 6 5 3 7 5 3 2 1
Fixed Assets 21 23 23 15 15 17 17 15 14 3
Liabilities
Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 3 6 7 7 5 8 6 6 7 0
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0
Shareholders' Equity
Total Equity 27 24 22 21 18 16 14 10 8 6
Share Capital 10 10 10 10 10 10 10 2 2 1
Reserves & Surplus 16 13 12 10 7 5 3 8 6 5

Tejnaksh Healthcare Income Statement Screener - Profit & Revenue Analysis

Screen Tejnaksh Healthcare income statement and profit fundamentals. Analyze TEJNAKSH quarterly results, revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Tejnaksh Healthcare share price evaluation.
Item 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun 2024-Sept 2024-Dec 2023-Mar 2023-Jun 2023-Sept 2023-Dec 2022-Mar 2022-Jun 2022-Sept
Revenue 3 3 3 3 3 3 4 3 3 3 3 3 3 3 4
Expenses 3 2 2 2 2 2 2 2 2 3 2 2 2 2 2
EBITDA 1 1 1 1 1 1 1 1 1 1 1 1 1 1 2
Operating Profit % 22.00% 23.00% 26.00% 26.00% 31.00% 34.00% 34.00% 36.00% 14.00% 17.00% 37.00% 34.00% 37.00% 38.00% 43.00%
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 1 0 1 0 1 1 1 1 0 0 1 1 1 1 1
Tax 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Profit 0 0 0 0 1 1 1 1 0 0 1 1 1 1 1
EPS 0.21 0.12 0.15 0.14 0.25 0.29 0.31 0.38 -0.01 0.08 0.28 0.27 0.53 0.55 0.82

Tejnaksh Healthcare Cash Flow Screener - Liquidity Fundamentals

Screen TEJNAKSH cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
Item 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March
Operating Activities 0 4 2 9 1 1 3 5 2 4
Investing Activities 4 -1 -1 -11 2 -1 -2 -3 -8 -3
Financing Activities -4 -2 -1 2 -3 0 -2 -1 6 0
Net Cash Flow 0 1 -1 0 0 0 -1 1 1 0

Tejnaksh Healthcare Shareholding Pattern Screener

See Tejnaksh Healthcare shareholding pattern with promoter, FII, and DII holdings. Check Tejnaksh Healthcare promoter holding and ownership changes for TEJNAKSH on TickJournal.
Item 2026-Mar 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun 2024-Sept
Promoter Holding 73.83% 73.83% 73.83% 73.83% 73.83% 73.83% 73.83% 73.83%
FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.28% 0.00% 0.00%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 23.58% 23.58% 23.60% 23.73% 23.72% 22.21% 23.49% 23.84%
Other Holding 2.59% 2.58% 2.57% 2.44% 2.44% 3.68% 2.68% 2.33%
Shareholder Count 4,414 4,493 4,552 4,550 4,452 3,502 3,776 4,067

Tejnaksh Healthcare Share Dividend Screener - Share Yield Analysis

Check Tejnaksh Healthcare dividend history with payout and yield data. View Tejnaksh Healthcare dividend details including ex-dates and amounts for TEJNAKSH stock.
No dividends declared by Tejnaksh Healthcare.

Tejnaksh Healthcare Stock Index Membership

See which indices include Tejnaksh Healthcare stock. Check TEJNAKSH index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Tejnaksh Healthcare is not part of any tracked indices.
Only major market indices are tracked in our system.

Tejnaksh Healthcare Market Events Screener - Corporate Actions

Get Tejnaksh Healthcare corporate actions including splits, bonuses, and buybacks. Check Tejnaksh Healthcare stock events that may affect TEJNAKSH share price.
Announcement Date Record Date Event Type Information Price Impact
Annual General Meeting NA -1.20%
Annual General Meeting NA -1.62%
2026-05-30 2026-05-30 Quarterly Result Announcement NA 8.30%
2026-02-07 2026-02-07 Quarterly Result Announcement NA 6.30%
2025-11-08 2025-11-08 Quarterly Result Announcement NA -1.66%
2025-08-14 2025-08-14 Quarterly Result Announcement NA -1.77%
2025-05-29 2025-05-29 Quarterly Result Announcement NA 0.72%
2025-02-22 2025-02-22 Extraordinary General Meeting NA -2.79%
2025-02-11 2025-02-11 Quarterly Result Announcement NA -0.42%
2024-11-14 2024-11-14 Quarterly Result Announcement NA -4.42%
2023-07-19 2023-05-20 Split 5:10 0.00%
2018-04-26 2018-04-28 Bonus 36:10 25.55%

Tejnaksh Healthcare Competitors Screener - Peer Comparison

Screen TEJNAKSH competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Dr. Lal Path Labs 27,159 53.50 2,763 8.15% 510 57.10
Vijaya Diagnostic Centre 13,053 72.87 814 16.36% 182 55.51
Metropolis Healthcare 11,101 56.27 1,646 22.25% 185 57.49
Thyrocare Technologies 7,944 45.59 829 18.06% 156 69.18
Nephrocare Health Services 6,194 79.31 999 29.74% 62 60.28
Krsnaa Diagnostics 1,855 22.68 743 16.70% 78 34.34
Suraksha Diagnostic 1,568 51.38 310 21.30% 34 53.40
3B BlackBio DX 1,036 17.70 112 28.72% 48 45.20
Health X Platform 1,006 33.22 1,171 -18.47% -134 69.84
One Global Service Provider 868 14.18 148 134.60% 19 43.09

Tejnaksh Healthcare Company Announcements - News Screener

Screen TEJNAKSH latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
Date Update Actions
2026-05-24 Board Meeting Intimation for Regulation 29 Of SEBI (LODR) Regulations 2015 -
2026-04-28 Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A -
2026-04-21 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-04-09 Reply To The Clarification Sought By The Stock Exchange With Reference To The Significant Movement In Share Price Of The Securities Of The Company; -
2026-04-08 Clarification sought from Tejnaksh Healthcare Ltd -
2026-03-27 Closure of Trading Window -
2026-02-07 Submission Of Un-Audited Financial Results (Standalone & Consolidated) For The Quarter Ended On 31St December 2025. -
2026-02-07 Board Meeting Outcome for Outcome Of Board Meeting In_Accordance With SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 Held On 7Th Feb 2026 -
2026-02-02 Board Meeting Intimation for 1. To Consider And Approve Un-Audited Financial Results (Standalone & Consolidated) For The Quarter 31St December 2025. 2. Any Other Matter With The Permission Of The Chair. -
2026-01-18 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2025-12-28 Closure of Trading Window -
2025-11-08 Submission Of Un-Audited Financial Results (Standalone & Consolidated) For The Quarter Ended On 30Th September 2025 -
2025-11-08 Board Meeting Outcome for Outcome Of Board Meeting In Accordance With SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 -
2025-11-02 Board Meeting Intimation for Regulation 29 Of SEBI (LODR) Regulations 2015 And Closure Of Trading Window -
2025-10-19 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2025-09-28 Announcement under Regulation 30 (LODR)-Change in Management -
2025-09-28 Announcement under Regulation 30 (LODR)-Change in Management -
2025-09-28 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2025-09-27 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2025-09-24 Closure of Trading Window -